Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Mosquito-Lethal Effect of Ivermectin in Healthy Adults
NCT03690453Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Feb 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ivermectin in malaria (2 arms), sponsored by University of Oxford. Primary endpoints: Area under the concentration-time curve at 41 days, Maximum concentration at 41 days and 3 more. Started Feb 2019; status: completed.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03690453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03690453.